Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis.
Desmet CJ, Gallenne T, Prieur A, Reyal F, Visser NL, Wittner BS, Smit MA, Geiger TR, Laoukili J, Iskit S, Rodenko B, Zwart W, Evers B, Horlings H, Ajouaou A, Zevenhoven J, van Vliet M, Ramaswamy S, Wessels LF, Peeper DS. Desmet CJ, et al. Among authors: van vliet m. Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5139-44. doi: 10.1073/pnas.1222085110. Epub 2013 Mar 12. Proc Natl Acad Sci U S A. 2013. PMID: 23483055 Free PMC article.
Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer.
Liu X, Holstege H, van der Gulden H, Treur-Mulder M, Zevenhoven J, Velds A, Kerkhoven RM, van Vliet MH, Wessels LF, Peterse JL, Berns A, Jonkers J. Liu X, et al. Among authors: van vliet mh, van der gulden h. Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12111-6. doi: 10.1073/pnas.0702969104. Epub 2007 Jul 11. Proc Natl Acad Sci U S A. 2007. PMID: 17626182 Free PMC article.
A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer.
Reyal F, van Vliet MH, Armstrong NJ, Horlings HM, de Visser KE, Kok M, Teschendorff AE, Mook S, van 't Veer L, Caldas C, Salmon RJ, van de Vijver MJ, Wessels LF. Reyal F, et al. Among authors: van t veer l, van vliet mh, van de vijver mj. Breast Cancer Res. 2008;10(6):R93. doi: 10.1186/bcr2192. Epub 2008 Nov 13. Breast Cancer Res. 2008. PMID: 19014521 Free PMC article.
Knowledge driven decomposition of tumor expression profiles.
van Vliet MH, Wessels LF, Reinders MJ. van Vliet MH, et al. BMC Bioinformatics. 2009 Jan 30;10 Suppl 1(Suppl 1):S20. doi: 10.1186/1471-2105-10-S1-S20. BMC Bioinformatics. 2009. PMID: 19208120 Free PMC article.
Oncogenic pathways impinging on the G2-restriction point.
Foijer F, Simonis M, van Vliet M, Wessels L, Kerkhoven R, Sorger PK, Te Riele H. Foijer F, et al. Among authors: van vliet m. Oncogene. 2008 Feb 14;27(8):1142-54. doi: 10.1038/sj.onc.1210724. Epub 2007 Aug 13. Oncogene. 2008. PMID: 17700522
Analytical Validation of SKY92 for the Identification of High-Risk Multiple Myeloma.
van Beers EH, Huigh D, Bosman L, de Best L, Kuiper R, Spaan M, van Duin M, Sonneveld P, Dumee B, van Vliet MH. van Beers EH, et al. Among authors: van vliet mh, van duin m. J Mol Diagn. 2021 Jan;23(1):120-129. doi: 10.1016/j.jmoldx.2020.10.010. Epub 2020 Nov 2. J Mol Diagn. 2021. PMID: 33152501 Free article.
Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma.
van Beers EH, van Vliet MH, Kuiper R, de Best L, Anderson KC, Chari A, Jagannath S, Jakubowiak A, Kumar SK, Levy JB, Auclair D, Lonial S, Reece D, Richardson P, Siegel DS, Stewart AK, Trudel S, Vij R, Zimmerman TM, Fonseca R. van Beers EH, et al. Among authors: van vliet mh. Clin Lymphoma Myeloma Leuk. 2017 Sep;17(9):555-562. doi: 10.1016/j.clml.2017.06.020. Epub 2017 Jul 4. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28735890
269 results